Challenges in Life Sciences: What 2020 Meant for This Industry
When we compare life sciences and healthcare to other industries, the strategy in the former is much more fragmented. The pricing practices are also relatively unbalanced while the product cycle is quite long as well.
James Woody Explores New Horizons in Enosi Life Sciences
Enosi Life Sciences announced that it has appointed Dr. James Woody as its Executive Chairman. Having immense leadership skills, Dr. James holds over 25 years of experience in the pharmaceutical, venture capital, and biotech sectors. He also possesses medical expertise in antibody therapeutics and oncology.
Life sciences and the state of its job market in the U.S.
The advent of coronavirus has threatened almost every job industry operating in the U.S. This has further affected the job market worldwide while creating a sense of fear among employees. Fortunately, the life sciences industry seems to be immune to the pandemic woes. The global deals within this sector accounted for $467 billion from 2013 to 2020.
Decibel Therapeutics Secures $82 Million
Decibel Therapeutics Inc., a Boston-based organization dedicated to treating hearing and balance disorders, is on the verge of another gene therapy breakthrough.
CereVasc Raises $43.9 Million for eShunt System
Cerevasc is a Boston-based company that develops novel treatments for people who are suffering from neurological diseases, like hydrocephalus
Asthma-Centered, Kinaset Therapeutics, Announces Funding
Newly-founded biopharmaceutical company, Kinaset Therapeutics, announced $40 million dollars in funding. The company, based in Medfield, Massachusetts, focuses on developing novel therapeutics...
Women Step in as Venture Capitalists in the Life Sciences Industry
It’s not surprising to associate male contributors as venture capitalists. 91% of VC decision-makers in the U.S. comprise male leadership.
Prelude Therapeutics Files for Its IPO
Prelude Therapeutics Incorporated files for its IPO. According to the S-1 filing, the IPO will see the company trade shares on the...
Symrise AG to Acquire Sensient Technologies
On Monday Nov. 23, Symrise AG's (SYIEY) fragrance business announced that it has entered into a definitive agreement to buy Sensient Technologies...
SPAC Frazier Lifesciences Acquisition Corporation Goes Public Looking for Opportunities in the Biotechnology Sector
Frazier Lifesciences Acquisition Corporation has recently filed paperwork with the SEC as part of its IPO process. This paperwork registers 10 million...